Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study.

BACKGROUND Time-domain T-wave alternans (TWA) is useful for identifying patients at risk for serious events after myocardial infarction. OBJECTIVE The purpose of this study was to prospectively evaluate the utility of time-domain TWA measured from Holter ECGs in predicting cardiac mortality in patients with left ventricular (LV) dysfunction. METHODS Two hundred ninety-five consecutive patients with LV dysfunction were enrolled in the study. Patients were divided into two groups: the ischemic group (n = 195) and the nonischemic group (n = 100). Time-domain TWA was assessed using the modified moving average method from routine 24-hour Holter ECGs recorded during daily activity. The maximal time-domain TWA voltage at heart rate <or=120 bpm in either lead V(5) or V(1) was derived and its value defined as positive when the voltage was >or=65 microV. The primary end-point was defined as cardiac mortality. RESULTS Mean maximal time-domain TWA voltage was 54 +/- 16 microV. During follow-up of 390 +/- 212 days, 27 patients (17 in the ischemic group and 10 in the nonischemic group) died of cardiac causes. Fifty-three patients (18%) were time-domain TWA positive and 242 (82%) were time-domain TWA negative. Univariate Cox proportional hazards analyses revealed that older age, New York Heart Association functional class III or IV, diabetes, renal dysfunction, nonsustained ventricular tachycardia, and time-domain TWA were associated with cardiac mortality. In multivariate analysis, time-domain TWA had the most significant value (hazard ratio = 17.1, P <.0001). This index also was significant in both subgroups (ischemic group: hazard ratio = 19.0, P <.0001; nonischemic group: hazard ratio = 12.3, P = .002). CONCLUSION Time-domain TWA measured from 24-hour Holter ECGs predicts cardiac mortality in patients with ischemic and nonischemic LV dysfunction.

[1]  Takanori Ikeda,et al.  T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. , 2002, The American journal of cardiology.

[2]  P. Stein,et al.  Ambulatory ECG‐Based T‐Wave Alternans Predicts Sudden Cardiac Death in High‐Risk Post‐MI Patients with Left Ventricular Dysfunction in the EPHESUS Study , 2008, Journal of cardiovascular electrophysiology.

[3]  R. Verrier,et al.  Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. , 2002, Journal of applied physiology.

[4]  S. Hohnloser,et al.  Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. , 2003, Journal of the American College of Cardiology.

[5]  P. Picton,et al.  Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans. , 2007, Journal of the American College of Cardiology.

[6]  Heikki Huikuri,et al.  T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. , 2007, European heart journal.

[7]  Takanori Ikeda,et al.  Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. , 2006, Journal of the American College of Cardiology.

[8]  Catherine Klersy,et al.  Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. , 2007, Journal of the American College of Cardiology.

[9]  J. A. Gomes,et al.  Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. , 2005, Journal of the American College of Cardiology.

[10]  Richard L. Verrier,et al.  Treatment options for patients with coronary artery disease identified as high risk by T-wave alternans testing , 2008, Current treatment options in cardiovascular medicine.

[11]  J Thomas Bigger,et al.  Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum , 2004, Circulation.

[12]  J. Bigger,et al.  Ambulatory Electrocardiogram‐Based Tracking of T Wave Alternans in Postmyocardial Infarction Patients to Assess Risk of Cardiac Arrest or Arrhythmic Death , 2003, Journal of cardiovascular electrophysiology.

[13]  S. Hohnloser,et al.  T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation , 2003, The Lancet.

[14]  G. Fick,et al.  Early After a Myocardial Infarction , 2007 .

[15]  A. Waldo,et al.  Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction , 2007 .

[16]  Brahmajee K Nallamothu,et al.  Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. , 2006, Journal of the American College of Cardiology.